Significant response to atezolizumab plus bevacizumab treatment in unresectable hepatocellular carcinoma with major portal vein tumor thrombus: a case report

Peer Review reports

Original Submission
21 Aug 2021	Submitted	Original manuscript
20 Oct 2021	Reviewed	Reviewer Report
30 Oct 2021	Reviewed	Reviewer Report
15 Nov 2021	Author responded	Author comments - Shohei Komatsu
Resubmission - Version 2
15 Nov 2021	Submitted	Manuscript version 2
Publishing
25 Nov 2021	Editorially accepted
15 Dec 2021	Article published	10.1186/s12876-021-02053-4

Back to article page